🕵️ Intellia Therapeutics, Inc. ($NTLA)
SEC insider & ownership activity, last 12 months · CIK 1652130 · every row links its SEC filing
Over the last 12 months insiders sold $2.2M against $1.4M of open-market buying. John M. Leonard sold $1.4M (Dec–Aug). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $1.4M (1 lots) · 7 sellers, $2.2M (19 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| John M. Leonard | 0 | – | 6 | $1.4M | Aug 21, 2026 |
| Fred E. Cohen | 1 | $1.4M | 0 | – | Jan 5, 2026 |
| Edward Dulac | 0 | – | 3 | $234K | Jul 22, 2026 |
| Basta James | 0 | – | 2 | $112K | Mar 2, 2026 |
| Lebwohl David | 0 | – | 1 | $110K | Jan 5, 2026 |
| Michael P. Dube | 0 | – | 3 | $104K | Jul 1, 2026 |
| Clark Eliana | 0 | – | 2 | $96K | Mar 2, 2026 |
| Birgit C. Schultes | 0 | – | 2 | $79K | Jan 5, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| ARK Investment Management LLC | 12.3% | 13G | Feb 3, 2026 | filing ↗ | |
| Catherine D. Wood | 12.3% | 13G | Feb 3, 2026 | filing ↗ | |
| BlackRock, Inc. | 8.2% | 13G | Apr 17, 2025 | filing ↗ | |
| State Street Corporation | 6.8% | 13G | Aug 7, 2026 | filing ↗ | |
| Vanguard Portfolio Management | 5.3% | 13G | Apr 29, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.0% | 13G | Apr 30, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| John M. Leonard | $294K | Aug 20, 2026 | filing ↗ |
| Edward Dulac | $81K | Jul 2, 2026 | filing ↗ |
| John M. Leonard | $822K | Dec 11, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Sep 8, 2026 | filing ↗ |
| Other events (8.01) | Sep 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 8, 2026 | filing ↗ |
| Material agreement (1.01) | Sep 4, 2026 | filing ↗ |
| New financial obligation (2.03) | Sep 4, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 4, 2026 | filing ↗ |
| Earnings (2.02) | Aug 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 13, 2026 | filing ↗ |
| Other events (8.01) | Jun 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 13, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 9, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 27, 2026 | filing ↗ |
| Earnings (2.02) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 27, 2026 | filing ↗ |
| Other events (8.01) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Apr 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 7, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 2, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 2, 2026 | filing ↗ |
| Other events (8.01) | Mar 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 2, 2026 | filing ↗ |
| Earnings (2.02) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 27, 2026 | filing ↗ |